Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nahdi Medical CoSAU:4164 +0.05%59 Receivables Turnover is 10.35 as of Mar. 2026. GuruFocus rates SAU:4164 with a GF Score™ of 59/100 and a GF Value™ of ﷼141.39 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 659 Healthcare Providers & Services companies, Nahdi Medical Co ranks better than 91.96% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Nahdi Medical Co's Revenue for the
three
months ended in Mar. 2026 was ﷼2,794 Mil. Nahdi Medical Co's average Accounts Receivable for the
three
months ended in Mar. 2026 was ﷼270 Mil.
Hence, Nahdi Medical Co's Receivables Turnover for the
three
months ended in Mar. 2026 was 10.35.
Nahdi Medical Co (SAU:4164) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Nahdi Medical Co Receivables Turnover Related Terms
Nahdi Medical Co Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Nahdi Medical Co's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nahdi Medical Co Receivables Turnover Competitor Comparison
For the Pharmaceutical Retailers subindustry, Nahdi Medical Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nahdi Medical Co Receivables Turnover vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nahdi Medical Co's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Nahdi Medical Co's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nahdi Medical Co (SAU:4164) has a Receivables Turnover of 10.35 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Nahdi Medical Co and its competitors. According to the industry distribution chart, Nahdi Medical Co ranks #53 out of 659 companies in the Healthcare Providers & Services industry, placing it in the top 8%.
Is Nahdi Medical Co's Receivables Turnover too high?
Nahdi Medical Co's current Receivables Turnover is 10.35. The Healthcare Providers & Services industry median Receivables Turnover is 7.96. Nahdi Medical Co's value of 10.35 is 30% above this industry median. Based on the distribution chart, Nahdi Medical Co ranks #53 out of 659 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Nahdi Medical Co has a GF Score™ of 59/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nahdi Medical Co's Receivables Turnover compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Nahdi Medical Co ranks #53 out of 659 companies for Receivables Turnover. This places Nahdi Medical Co in the top 8% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 7.96. Nahdi Medical Co's value of 10.35 is 30% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Healthcare Providers & Services company?
The median Receivables Turnover among Healthcare Providers & Services companies is 7.96, based on 659 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nahdi Medical Co's current Receivables Turnover of 10.35 is 30% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Nahdi Medical Co and its competitors. For the Healthcare Providers & Services industry, the median Receivables Turnover is 7.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nahdi Medical Co's current Receivables Turnover is 10.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nahdi Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Nahdi Medical Co (SAU:4164) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼141.39, compared to a current price of ﷼93.00 — trading 34.2% below its estimated fair value. The current Receivables Turnover is 10.35 and 30% above the Healthcare Providers & Services industry median of 7.96. Nahdi Medical Co's overall GF Score™ is 59/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Nahdi Medical Co (SAU:4164), the current Receivables Turnover is 10.35 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nahdi Medical Co (SAU:4164) Overvalued in 2026?
Based on GuruFocus' analysis, Nahdi Medical Co stock appears to be undervalued.
The current stock price of ﷼93.00 is trading 34.2% below its estimated GF Value™ of ﷼141.39.
GuruFocus considers Nahdi Medical Co to be Significantly Undervalued.
Key valuation signals for SAU:4164:
Receivables Turnover: 10.35
GF Value™: ﷼141.39 vs. price of ﷼93.00 (34.2% below fair value)
Industry Position: 30% above the Healthcare Providers & Services median (#53 of 659)
No single metric tells the full story. See the SAU:4164 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nahdi Medical Co is engaged in the wholesale and retail trading of cosmetics, pharmaceutical products, special and healthy foods, and medical equipment. It has two operating segments: Front Shop and Pharma.
59GF Score
Get the complete analysis for SAU:4164
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4164 has been successfully added to your 
